Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Animals (Basel) ; 13(14)2023 Jul 09.
Artigo em Inglês | MEDLINE | ID: mdl-37508027

RESUMO

The aim of this study was to determine the effect of supplementation with ethyl esters of linseed oil on the fatty acid profile in hair sebum, blood serum and erythrocyte membranes in healthy dogs. The material for the study included hair and blood samples of adult beagle dogs. The experiment was performed in two periods: summer and winter. Each time it lasted 16 weeks. During the first 8 weeks, the dogs received a supplement, the amount of which was determined individually so that the ratio of α-linolenic acid (ALA) to linoleic acid (LA) together in the feed and supplement was 1:1. Hair coat and blood samples were collected on days 0, 56 and 112; i.e., before the start of supplementation, after 8 weeks of supplementation and 8 weeks after supplementation was completed. The study included a determination of the fatty acid profile with a particular emphasis on polyunsaturated fatty acids (PUFAs) and the ratio of omega-6 to omega-3 in hair sebum, blood serum and erythrocyte membranes. As a result of supplementation, a significant decrease in saturated acids and an increase in unsaturated acids was observed in hair sebum both in summer and winter and especially in omega-3 fatty acids; i.e., α-linolenic (ALA) and its derivatives eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). The same relationships were observed in blood serum and in erythrocyte cell membranes in all the studied periods. Additionally, 8 weeks after the end of supplementation, the level of polyunsaturated fatty acids was still higher compared to the period before supplementation. Moreover, the supplementation resulted in a favorable decrease in the ratio of omega-6 to omega-3 acids in the tested samples, which persisted even after the withdrawal period.

2.
Arch Anim Breed ; 62(1): 99-105, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31807619

RESUMO

The most important nutrients affecting wool production include sulfur amino acids, such as methionine, and minerals, such as zinc, and their deficiency may cause wool production decrease. The aim of this study was to evaluate an effect of zinc and methionine chelate addition on the qualitative characteristics of Merino ewes wool and zinc content in wool fibers and on their surface. Histological evaluation of fibers was also performed. The study included 22 Polish Merino ewes divided into two groups: control and experimental (0.4 g chelates daily per head). The experiment lasted for 4 months (3.5 months of pregnancy and 2 weeks of early lactation). The length, thickness and breaking force of wool fibers were higher in the experimental group compared to the control group. Higher content of zinc in wool of sheep from the experimental group was also demonstrated. The histological structure of fibers from both groups did not differ, as the content of zinc on their surface. It can be concluded on the basis of the obtained results that the addition of chelates favorably influenced the thickness compensation of wool fibers and amount of wool obtained from sheep during pregnancy and early lactation, as well as mechanical features of wool.

3.
Nutrients ; 10(10)2018 Oct 21.
Artigo em Inglês | MEDLINE | ID: mdl-30347877

RESUMO

Cardiovascular diseases are described as the leading cause of morbidity and mortality in modern societies. Therefore, the importance of cardiovascular diseases prevention is widely reflected in the increasing number of reports on the topic among the key scientific research efforts of the recent period. The importance of essential fatty acids (EFAs) has been recognized in the fields of cardiac science and cardiac medicine, with the significant effects of various fatty acids having been confirmed by experimental studies. Polyunsaturated fatty acids are considered to be important versatile mediators for improving and maintaining human health over the entire lifespan, however, only the cardiac effect has been extensively documented. Recently, it has been shown that omega-3 fatty acids may play a beneficial role in several human pathologies, such as obesity and diabetes mellitus type 2, and are also associated with a reduced incidence of stroke and atherosclerosis, and decreased incidence of cardiovascular diseases. A reasonable diet and wise supplementation of omega-3 EFAs are essential in the prevention and treatment of cardiovascular diseases prevention and treatment.


Assuntos
Doenças Cardiovasculares/prevenção & controle , Ácidos Graxos Insaturados , Suplementos Nutricionais , Humanos
4.
Curr Med Chem ; 23(8): 816-31, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-26795198

RESUMO

Polyunsaturated fatty acids (PUFAs) are crucial for our health and wellbeing; therefore, they have been widely investigated for their roles in maintaining human health and in disease treatment. Most Western diets include significant amount of saturated and omega-6 fatty acids and insufficient quantity of omega-3; however, the balance between omega-6 and omega-3 PUFA, in particular, is essential for the formation of pro- and anti-inflammatory lipids to promote health and prevent disease. As our daily diet affects our health, this paper draws attention to unique representatives of the omega-3 fatty acid group: alpha-linolenic acid and its derivatives. Recently, this has been shown to be effective in treating and preventing various diseases. It has been confirmed that omega-3 PUFAs may act as therapeutic agents as well and their significant role against inflammatory diseases, such as cardiovascular and neurodegenerative diseases, has been described. Some of nutritional factors have been described as a significant modifiers, which can influence brain elasticity and thus, effect on central nervous system functioning. Therefore, appropriate dietary management appears to be a non-invasive and effective approach to counteract neurological and cognitive disorders.


Assuntos
Doenças do Sistema Nervoso Central/dietoterapia , Doenças do Sistema Nervoso Central/prevenção & controle , Sistema Nervoso Central/metabolismo , Ácidos Graxos Ômega-3/metabolismo , Ácidos Graxos Ômega-3/uso terapêutico , Doenças do Sistema Nervoso Central/metabolismo , Transtornos Cognitivos/dietoterapia , Transtornos Cognitivos/metabolismo , Transtornos Cognitivos/prevenção & controle , Ácidos Graxos Ômega-3/química , Humanos , Estrutura Molecular
5.
Curr Drug Metab ; 12(7): 667-78, 2011 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-21561431

RESUMO

L-Carnitine is an endogenous molecule involved in fatty acid metabolism, biosynthesized within the human body using amino acids: L-lysine and L-methionine, as substrates. L-Carnitine can also be found in many foods, but red meats, such as beef and lamb, are the best choices for adding carnitine into the diet. Good carnitine sources also include fish, poultry and milk. Essentially, L-carnitine transports the chains of fatty acids into the mitochondrial matrix, thus allowing the cells to break down fat and get energy from the stored fat reserves. Recent studies have started to shed light on the beneficial effects of L-carnitine when used in various clinical therapies. Because L-carnitine and its esters help reduce oxidative stress, they have been proposed as a treatment for many conditions, i.e. heart failure, angina and weight loss. For other conditions, such as fatigue or improving exercise performance, L-carnitine appears safe but does not seem to have a significant effect. The presented review of the literature suggests that continued studies are required before L-carnitine administration could be recommended as a routine procedure in the noted disorders. Further research is warranted in order to evaluate the biochemical, pharmacological, and physiological determinants of the response to carnitine supplementation, as well as to determine the potential benefits of carnitine supplements in selected categories of individuals who do not have fatty acid oxidation defects.


Assuntos
Carnitina/metabolismo , Carnitina/farmacologia , Estresse Oxidativo/fisiologia , Animais , Carnitina/uso terapêutico , Suplementos Nutricionais , Insuficiência Cardíaca/tratamento farmacológico , Insuficiência Cardíaca/metabolismo , Humanos , Metabolismo dos Lipídeos/efeitos dos fármacos , Metabolismo dos Lipídeos/fisiologia , Redes e Vias Metabólicas/efeitos dos fármacos , Redes e Vias Metabólicas/fisiologia , Estresse Oxidativo/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA